Form EFFECT Scinai Immunotherapeutic
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 19, 2026 9:00 A.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hofseth Biocare ASA: Notification of major shareholdings
- WORLDLINE : Divestment of ANZ Worldline Payment Solutions JV in Australia to ANZ finalised
- Intropy Announces $11 Million in Funding to Build the AI-Native Operating System for the Spare Parts Supply Chain
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share